Detalhe da pesquisa
1.
COVID-19-Related Outcomes Among Group Home Residents with Serious Mental Illness in Massachusetts in the First Year of the Pandemic.
Adm Policy Ment Health
; 51(1): 60-68, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37938475
2.
Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens.
Breast Cancer Res Treat
; 188(2): 449-458, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33909203
3.
Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 16(10): 1216-1247, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30323092
4.
Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 15(9): 1140-1163, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28874599
5.
NCCN Guidelines Insights: Survivorship, Version 1.2016.
J Natl Compr Canc Netw
; 14(6): 715-24, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27283164
6.
Hypomethylation of the MMP7 promoter and increased expression of MMP7 distinguishes the basal-like breast cancer subtype from other triple-negative tumors.
Breast Cancer Res Treat
; 146(1): 25-40, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24847890
7.
A breast multi-disciplinary genomic tumor board is feasible and can provide timely and impactful recommendations.
Breast J
; 24(4): 676-677, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29517142
8.
Group Home Staff Experiences With Work and Health in the COVID-19 Pandemic in Massachusetts.
JAMA Health Forum
; 4(4): e230445, 2023 04 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37027164
9.
Best practices to reduce COVID-19 in group homes for individuals with serious mental illness and intellectual and developmental disabilities: Protocol for a hybrid type 1 effectiveness-implementation cluster randomized trial.
Contemp Clin Trials
; 125: 107053, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36539061
10.
A phase II study of 17-allylamino-17-demethoxygeldanamycin in metastatic or locally advanced, unresectable breast cancer.
Breast Cancer Res Treat
; 131(3): 933-7, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22083229
11.
Neglecting to screen women between the ages of 40 and 49 years with mammography: what is the impact on breast cancer diagnosis?
AJR Am J Roentgenol
; 198(5): 1218-22, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22528917
12.
Biosimilar strategic implementation at a large health system.
Am J Health Syst Pharm
; 79(4): 268-275, 2022 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34752608
13.
Early Local Therapy for the Primary Site in De Novo Stage IV Breast Cancer: Results of a Randomized Clinical Trial (EA2108).
J Clin Oncol
; 40(9): 978-987, 2022 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34995128
14.
Emerging radiation techniques for early-stage breast cancer after breast-conserving surgery.
Future Oncol
; 7(7): 915-25, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21732760
15.
Cisplatin +/- rucaparib after preoperative chemotherapy in patients with triple-negative or BRCA mutated breast cancer.
NPJ Breast Cancer
; 7(1): 29, 2021 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33753748
16.
Sapanisertib Plus Exemestane or Fulvestrant in Women with Hormone Receptor-Positive/HER2-Negative Advanced or Metastatic Breast Cancer.
Clin Cancer Res
; 27(12): 3329-3338, 2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33820779
17.
A vasculature-targeting regimen of preoperative docetaxel with or without bevacizumab for locally advanced breast cancer: impact on angiogenic biomarkers.
Clin Cancer Res
; 15(10): 3583-90, 2009 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19417018
18.
Lower-dose vs high-dose oral estradiol therapy of hormone receptor-positive, aromatase inhibitor-resistant advanced breast cancer: a phase 2 randomized study.
JAMA
; 302(7): 774-80, 2009 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-19690310
19.
Feasibility of a team based prognosis and treatment goal discussion (T-PAT) with women diagnosed with advanced breast cancer.
Patient Educ Couns
; 102(1): 77-84, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30150125
20.
Inflammatory breast cancer as a model disease to study tumor angiogenesis: results of a phase IB trial of combination SU5416 and doxorubicin.
Clin Cancer Res
; 13(19): 5862-8, 2007 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17908980